SavedAdd your journal

Journals / Causapedia / 2016 / Cilt: 5 - Sayı: 2

Myelodisplastik Sendromda Koroner Arter Hastalığına OPCAB Üçlü Bypass Tedavi Seçeneği

OPCAB treatment option for Coronary Artery Disease in Myelodisplastic Syndrome

TUĞRA GENÇPINAR
Gökmen AKKAYA
Çağatay BİLEN
Barış KEMAHLI
Öztekin OTO
Journal
Causapedia
Pages
125–130
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

He wasstabilized after increasing the number of platelets.Herein, we have published this case due to its rarityand difficulty in decision-making

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The aim of this study is evaluate the outcomes ofmyelodysplastic syndrome on multivessel coronaryartery disease.
📊
Key Findings & Data:A 72-year-old male who had beendiagnosed as myelodysplastic syndrome (MDS)referred for effort angina.
💡
Conclusion & Impact:He wasstabilized after increasing the number of platelets.Herein, we have published this case due to its rarityand difficulty in decision-making
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

The aim of this study is evaluate the outcomes ofmyelodysplastic syndrome on multivessel coronaryartery disease. A 72-year-old male who had beendiagnosed as myelodysplastic syndrome (MDS)referred for effort angina. On coronary angiography,critical 80% stenosis of the left main coronary arteryand multivessel coronary artery disease (MVCAD)determined. On complete blood count the number ofplatelets was about 10-20^3/µL. We administeredplatelet replacement twice daily to increase thenumber of platelets to prevent hemorrhage for a week.This case was characterized with hemodynamicinstability and difficulties in MDS after off pumpcoronary artery bypass grafting (OPCAB) due tothrombocytopenia of varying severity. He wasstabilized after increasing the number of platelets.Herein, we have published this case due to its rarityand difficulty in decision-making

Özet

Bu çalışmanın amacı, çoklu damar koroner arterhastalığındaetkilerini araştırmaktır. Bilinen MDS tanılı 72 yaşındaerkek hasta, efor anjinası ile başvurdu. Koroneranjiografisinde, özellikle sol ana koroner arter de %80darlık olmak üzere çoklu segment koroner damarhastalığı (MVCAD) tespit edildi. Tam kan sayımında,trombosit sayısı 10-20^3/µL olarak ölçüldü. Trombositsayısını arttırmak ve hemoraji gelişmesini önlemekamacı ile günlük iki kez, bir hafta boyunca trombositreplasmanı uygulandı. Bu olgu, çalışan kalp koronerbypass cerrahisi (OPCAB) sonrası; hemodinamikuygunsuzluk ve MDS'daki klinik zorluklar ile değişikderecelerde ciddi trombositopeni olması nedeniyleönemliydi. Hasta stabilizasyonu, trombosit sayısınınarttırılması sonrasında sağlandı. Bu olgu, nadirrastlanması ve tedavi algoritmasındaki karar vermezorlukları sebebi ile sunulmuştur

🔖

Cite This Article

GENÇPINAR, T., AKKAYA, G., BİLEN, Ç., KEMAHLI, B., OTO, Ö. (2016). Myelodisplastik Sendromda Koroner Arter Hastalığına OPCAB Üçlü Bypass Tedavi Seçeneği. Causapedia, Cilt: 5 - Sayı: 2, 125–130. https://ajindex.com/articles/175477

References (10)

  1. Cavolli R, Uymaz B, Memishaj S, et al. A rare case of left main coronary stenosis and neutropenia treated with G-CSF prior to CABG. Thorac Cardiovasc Surg 2010;58(8):488-9
  2. Miyagi Y, Yamauchi S, Suzuki S, et al. Investigation of coronary artery bypass grafting for a patient with myelodysplastic syndrome. Ann Thorac Cardiovasc Surg. 2001;7(4):250-3
  3. Ng CY, Ramli MF, Awang Y. Coronary bypass surgery in patients aged 70 years and over: mortality, morbidity, length of stay and hospital cost. Asian Cardiovasc Thorac Ann 2004;12(3): 218-23
  4. Bakaeen FG, Chu D, Kelly RF, et al. Perioperative outcomes after on- and off-pump coronary artery bypass grafting. Tex Heart Inst J 2014;41(2):144-51
  5. Sepehripour AH, Harling L, Ashrafian H, et al. Does off-pump coronary revascularization confer superior organ protection in re-operative coronary artery surgery? A meta-analysis of observational studies. J Cardiothorac Surg. 2014 24;9(1):115
  6. Ganti AK, Potti A, Koka VK, et al. Myeloproliferative syndromes and the associated risk of coronary artery disease. Thromb Res. 2003;110(2-3):83-6
  7. Gangwani AL, Hamid M, Naz F. Aortic valve replacement in a patient with pancytopenia secondary to myelodysplastic syndrome. J Pak Med Assoc. 2014;64(2):207-9
  8. Enblom A, Lindskog E, Hasselbalch H, et al. High rate of abnormal blood values and vascular complications before diagnosis of myeloproliferative neoplasms. Eur J Intern Med. 2015;26(5):344-7
  9. Wu J, Zhang L, Vaze A, et al. Risk of Wernicke's encephalopathy and cardiac disorders in patients with myeloproliferative neoplasm. Cancer Epidemiol. 2015;39(2):242-9
  10. Wang Y, Zuo A, Liu Y, et al. Complications and conversions in myeloproliferative disorders: an analysis of 356 cases. Zhonghua Xue Ye Xue Za Zhi. 2002;23(6):314-7.